A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

Clinical trial NCT07623200 · RECRUITING

Trial details

NCT number: NCT07623200
Sponsor: Incyte Corporation
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Thrombocythemia

Start date: 2026-09-08
Primary completion: 2029-06-15
Enrollment: 426

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.